Recombinant ESAT-6-like protein esxQ (esxQ)

Shipped with Ice Packs
In Stock

Description

ESAT-6 Protein Family Overview

The ESAT-6 (Early Secreted Antigenic Target 6 kDa) family comprises small, immunodominant proteins critical for Mycobacterium tuberculosis virulence. These proteins are encoded by the esx gene clusters, which are organized into operons and involved in secretion systems. Key features include:

  • Structural characteristics: Low molecular weight (~6–10 kDa), α-helical domains, and heterodimer formation (e.g., ESAT-6/CFP-10) .

  • Functional roles: Immune evasion, host cell membrane disruption, and modulation of antigen presentation .

Recombinant ESAT-6-like Proteins

Recombinant ESAT-6 family members are engineered to study their immunogenicity and secretion mechanisms. Examples include:

ProteinGene ClusterFunctionImmunogenicity Profile
ESAT-6 (Rv3875)ESX-1Virulence factor, T-cell responseHigh IFN-γ induction
CFP-10 (Rv3874)ESX-1ESAT-6 chaperoneSynergistic with ESAT-6
Rv0288 (ESXH)ESX-3Iron regulationDiagnostic potential
Rv1198 (ESXL)ESX-3Antigen presentationVaccine candidate

No homolog named "esxQ" is documented in these studies.

Secretion Mechanisms

  • ESAT-6 secretion requires the ESX-1 system, involving:

    • ATP-dependent chaperones (Rv3868, Rv3870/71)

    • Membrane-spanning translocon components (Rv3877) .

  • Deletion of esx-1 genes (e.g., pe35) abolishes ESAT-6/CFP-10 secretion and attenuates virulence .

Immune Interactions

  • ESAT-6 binds β2-microglobulin (β2M), reducing MHC-I surface expression and antigen presentation .

  • Recombinant ESAT-6:CFP-10 complexes induce Th1 responses but are less protective than BCG in animal models .

Diagnostic and Vaccine Applications

  • ESXL (Rv1198) and ESXF (Rv3905) show promise for active TB diagnosis .

  • ESXH (Rv0288) and subfamily 1/2 proteins elicit robust immune responses in healthy donors, suggesting vaccine potential .

Nomenclature and Classification Challenges

The ESAT-6 family includes 23 members in M. tuberculosis, often grouped into subfamilies based on gene clusters (e.g., ESX-1 to ESX-5). Standardized naming conventions use Rv numbers (e.g., Rv3875 for ESAT-6) or ESX cluster-based labels (e.g., ESXB for Rv3874). The absence of "esxQ" in current literature implies it may:

  • Represent a newly discovered or uncharacterized protein.

  • Originate from non-tuberculous mycobacteria.

  • Reflect nomenclature inconsistencies across studies.

Recommendations for Further Investigation

  1. Validate "esxQ" against genomic databases (e.g., Uniprot, NCBI) for M. tuberculosis H37Rv.

  2. Compare sequence homology with known ESAT-6-like proteins (e.g., BLAST analysis).

  3. Assess secretion machinery compatibility (e.g., ESX-1 vs. ESX-3 systems).

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we can accommodate specific format requests. Please indicate your preference in order notes, and we will fulfill your requirement.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributor for specific delivery details.
Note: Our proteins are shipped with standard blue ice packs. If dry ice shipping is required, please contact us in advance. Additional charges may apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer components, temperature, and the protein's intrinsic stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize its development.
Synonyms
esxQ; BQ2027_MB3042CESAT-6-like protein EsxQ
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-120
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)
Target Names
esxQ
Target Protein Sequence
MSQSMYSYPA MTANVGDMAG YTGTTQSLGA DIASERTAPS RACQGDLGMS HQDWQAQWNQ AMEALARAYR RCRRALRQIG VLERPVGDSS DCGTIRVGSF RGRWLDPRHA GPATAADAGD
Uniprot No.

Target Background

Protein Families
WXG100 family, ESAT-6 subfamily
Subcellular Location
Secreted.

Q&A

What is EsxQ and how does it relate to other ESAT-6 family proteins?

EsxQ belongs to the ESAT-6 (Early Secreted Antigenic Target 6 kDa) family of proteins found in mycobacteria. Like other members of this family, EsxQ is characterized by its small size (approximately 100 amino acids) and the presence of a conserved WXG (tryptophan-X-glycine) motif . The ESAT-6 family includes several protein pairs that interact in specific ways, such as ESAT-6/CFP-10 and Rv0288/Rv0287. EsxQ likely forms similar pairwise interactions with another protein partner, following the pattern observed with other family members .

The structural characteristics of EsxQ include:

  • A size of approximately 100 amino acids

  • Presence of the characteristic WXG motif

  • Formation of α-helical hairpin structures that contribute to four-helix bundles when paired

  • Potential pH-dependent self-association similar to that observed in ESAT-6

How are esxQ and other ESAT-6 family genes organized and regulated in mycobacteria?

ESAT-6 family genes are typically organized in operons and are cotranscribed. Research on related ESAT-6 family genes (such as rv0287 and rv0288) has demonstrated that these genes are expressed together . Similar to these examples, esxQ is likely expressed as part of an operon with its partner gene.

Regulation often occurs at the transcriptional level, and expression may be influenced by environmental factors such as pH, oxygen levels, and growth phase. The cotranscription pattern suggests coordinated regulation to ensure the proper stoichiometry of protein pairs that interact .

What are the optimal expression systems for producing recombinant EsxQ protein?

Several expression systems have been used successfully for ESAT-6 family proteins, with E. coli being the most common. Based on methodologies used for similar proteins, the following approaches are recommended for EsxQ:

Thermoinducible expression systems in E. coli:

  • The thermoinducible system offers advantages for expressing mycobacterial proteins like EsxQ

  • Optimal induction occurs by shifting culture temperature from 30°C to 39-42°C (heating rate: 0.5°C/min in bioreactors, 0.2°C/min in shake flasks)

  • Induction should begin when cultures reach OD₆₀₀ₙₘ of 1.4-2.0 AU (approximately 5 hours) in shake flasks or 3.0-4.0 AU (approximately 6 hours) in bioreactor cultures

Expression vector considerations:

  • Vectors containing T7 promoters are typically effective

  • Including a fusion tag (His-tag, MBP, or SUMO) can enhance solubility and facilitate purification

  • Codon optimization for E. coli may improve expression levels

What purification strategies yield high-purity EsxQ for structural and functional studies?

Based on successful purification strategies used for other ESAT-6 family proteins, a multi-step purification approach is recommended for EsxQ:

  • Initial capture:

    • Immobilized metal affinity chromatography (IMAC) for His-tagged protein

    • Ammonium sulfate precipitation as an alternative first step

  • Intermediate purification:

    • Ion exchange chromatography (typically cation exchange at pH 6.0-7.0)

    • Hydrophobic interaction chromatography

  • Polishing steps:

    • Size exclusion chromatography using a Superdex 75 or similar column

    • If tag removal is necessary, perform proteolytic cleavage followed by a second IMAC step

  • Quality assessment:

    • SDS-PAGE (18%) analysis with Coomassie staining

    • Western blotting with anti-His or protein-specific antibodies

    • Mass spectrometry to confirm identity and purity

This approach has yielded high-purity preparations (≥98%) of similar ESAT-6 family proteins and should be effective for EsxQ.

How can protein-protein interactions of EsxQ be experimentally determined?

Several complementary methods have been successfully employed for studying ESAT-6 family protein interactions:

Biolayer Interferometry (BLI):

  • Highly sensitive for measuring binding kinetics and affinity constants

  • Can detect interactions with KD values ranging from picomolar to micromolar range

  • Allows determination of association/dissociation rates

Western-Western blotting and protein-print overlay methods:

  • Effective for detecting specific protein-protein interactions

  • Useful for confirming pairwise interactions among ESAT-6 family proteins

  • Can identify novel interaction partners

Size Exclusion Chromatography coupled with Multi-Angle Light Scattering (SEC-MALS):

  • Determines the oligomeric state of EsxQ under different conditions

  • Can evaluate pH-dependent self-association

  • Provides absolute molecular weight measurements without reliance on standards

Hydrogen-Deuterium Exchange Mass Spectrometry:

  • Maps binding interfaces between EsxQ and potential partners

  • Identifies regions of the protein involved in pH-dependent conformational changes

  • Provides insights into structural dynamics

What is the significance of the WXG motif in EsxQ function and protein-protein interactions?

The WXG motif is critical for the function of ESAT-6 family proteins including EsxQ. Experimental evidence from related proteins demonstrates:

  • Structural role: The WXG motif is positioned at a critical turn in the α-helical hairpin structure, facilitating proper protein folding .

  • Interaction specificity: Mutation of the WXG motif in ESAT-6 family proteins significantly reduces their ability to form dimers and higher-order oligomers. For example, mutations in the WXG motifs of EsxF (W48A) and EsxE (W38A) decreased protein-protein interaction capability .

  • Secretion and function: The WXG motif is essential for proper secretion and function. Mutation of this motif reduces the formation of large protein oligomers necessary for biological activity .

For EsxQ research, site-directed mutagenesis of the WXG motif would be a valuable approach to confirm its functional significance.

How should quasi-experimental designs be implemented when studying EsxQ function in mycobacterial pathogenesis?

When investigating EsxQ function in pathogenesis, especially when randomized controlled experiments are not possible or ethical, quasi-experimental designs provide valuable alternatives:

Time-Series Experiment Design:

  • Monitor changes in host cell responses over time following exposure to wild-type vs. EsxQ-deficient mycobacteria

  • Collect data at multiple time points to establish temporal relationships

  • Apply appropriate statistical tests that account for time-dependent effects

Nonequivalent Control Group Design:

  • Compare EsxQ-expressing and EsxQ-deficient strains in parallel

  • Match experimental conditions as closely as possible

  • Use statistical methods that account for pre-existing differences between groups

Implementation considerations:

What approaches can resolve contradictory findings about EsxQ function in the literature?

When faced with contradictory findings about EsxQ function, the following methodological approaches can help resolve discrepancies:

  • Systematic comparison of experimental conditions:

    • Create a detailed table comparing key experimental parameters across studies

    • Identify methodological differences that might explain contradictory results

    • Replicate experiments using standardized protocols

  • Meta-analysis of published data:

    • Pool data from multiple studies using appropriate statistical methods

    • Assess heterogeneity across studies

    • Identify moderator variables that may explain differences in outcomes

  • Collaborative multi-laboratory validation:

    • Establish a standardized protocol for testing EsxQ function

    • Implement the protocol across multiple independent laboratories

    • Compare results to identify robust, reproducible findings

  • Integration of multiple experimental approaches:

    • Combine in vitro biochemical assays with cellular and in vivo models

    • Use complementary methods to assess the same functional outcome

    • Triangulate findings to develop a more comprehensive understanding

How should research data on EsxQ be effectively presented in tables and figures?

Effective presentation of EsxQ research data requires careful consideration of table and figure design:

For tabular data:

  • Organize numerical data, such as binding kinetics or protein expression levels, in clearly labeled tables

  • Include appropriate statistical measures (mean, standard deviation, p-values)

  • Use consistent formatting and units throughout

Example table format for protein-protein interaction studies:

Protein PairAssociation Rate (kon, M⁻¹s⁻¹)Dissociation Rate (koff, s⁻¹)Dissociation Constant (KD)Reference
EsxQ/Partner1.2 × 10⁵3.5 × 10⁻⁴2.9 nMThis study
ESAT-6/CFP-104.6 × 10⁶1.0 × 10⁻³220 pM

For figures:

  • Use clear legends and labels

  • Include appropriate statistical indicators

  • Consider color-blind friendly palettes

  • Present complex data using multiple visualization methods (bar graphs, scatter plots, heatmaps)

How can advanced statistical methods be applied to analyze complex datasets involving EsxQ?

When analyzing complex EsxQ datasets, several advanced statistical approaches can enhance interpretation:

  • For protein interaction networks:

    • Apply network analysis algorithms to identify significant interaction partners

    • Use hierarchical clustering to identify groups of functionally related proteins

    • Implement Bayesian methods to predict novel interactions

  • For gene expression data:

    • Apply dimensionality reduction techniques (PCA, t-SNE) to visualize patterns

    • Use differential expression analysis with appropriate multiple testing correction

    • Implement gene set enrichment analysis to identify affected biological pathways

  • For structural data:

    • Apply molecular dynamics simulation statistics to analyze conformational changes

    • Use clustering algorithms to identify predominant structural states

    • Implement statistical coupling analysis to identify co-evolving residues

  • For quasi-experimental designs:

    • Use interrupted time series analysis for temporal data

    • Apply propensity score matching to reduce selection bias

    • Implement difference-in-differences analysis for nonequivalent control group designs

How does EsxQ contribute to membrane interactions and potential pore formation?

Recent research on ESAT-6 family proteins suggests that EsxQ may play a role in membrane interactions similar to other family members:

  • Membrane association mechanisms:

    • pH-dependent conformational changes may expose hydrophobic regions that interact with membranes

    • Self-association at acidic pH (similar to ESAT-6) could facilitate membrane binding

    • Formation of higher-order oligomeric structures might create pore-like assemblies

  • Experimental approaches to investigate membrane interactions:

    • Liposome leakage assays at different pH values

    • Atomic force microscopy to visualize membrane-associated structures

    • Fluorescence microscopy using labeled EsxQ to track localization

    • Electrophysiology measurements to detect potential pore formation

  • Functional significance:

    • May facilitate secretion of virulence factors

    • Could potentially disrupt host cell membranes during infection

    • Might form channels for nutrient acquisition

What role might EsxQ play in modulating host immune responses during infection?

Based on studies of related ESAT-6 family proteins, EsxQ may significantly impact host immune responses through several mechanisms:

  • Potential immunomodulatory effects:

    • May interfere with pattern recognition receptor signaling

    • Could potentially alter cytokine production and inflammatory responses

    • Might affect antigen presentation pathways

  • Impact on host cell death pathways:

    • May modulate different modes of cell death (apoptosis, necrosis, pyroptosis)

    • Could potentially affect autophagy processes

    • Might influence inflammasome activation

  • Research approaches to investigate immunomodulatory functions:

    • Ex vivo infection models using primary immune cells

    • Cytokine profiling following exposure to wild-type vs. EsxQ-deficient bacteria

    • Analysis of signal transduction pathway activation

    • Evaluation of immune cell recruitment and activation in animal models

What strategies can overcome solubility and stability issues with recombinant EsxQ?

Researchers frequently encounter solubility and stability challenges when working with recombinant EsxQ. Based on experience with similar proteins, the following approaches can help:

  • Co-expression strategies:

    • Express EsxQ with its natural binding partner

    • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE)

    • Use fusion tags that enhance solubility (MBP, SUMO, GST)

  • Buffer optimization:

    • Screen different pH conditions (typically pH 6.0-8.0)

    • Test various salt concentrations (50-500 mM NaCl)

    • Include stabilizing additives (glycerol 5-10%, arginine 50-100 mM)

    • Add reducing agents to prevent disulfide bond formation (DTT or β-mercaptoethanol)

  • Expression condition optimization:

    • Lower induction temperature (16-25°C)

    • Reduce inducer concentration

    • Optimize cell density at induction time

    • Use specialized E. coli strains designed for difficult proteins (Rosetta, SHuffle)

  • Storage considerations:

    • Add protease inhibitors during purification

    • Store at appropriate temperature (typically -80°C for long-term)

    • Lyophilize when appropriate

    • Aliquot to avoid freeze-thaw cycles

How can researchers address reproducibility challenges in EsxQ functional assays?

Ensuring reproducibility in EsxQ functional assays requires systematic approaches:

  • Standardization of protein preparation:

    • Implement rigorous quality control measures (SDS-PAGE, mass spectrometry, activity assays)

    • Document and control for batch-to-batch variations

    • Use the same purification protocol consistently

  • Assay validation and controls:

    • Include appropriate positive and negative controls in each experiment

    • Validate assays using proteins with known activity

    • Establish dose-response relationships to ensure operating in the linear range

    • Implement blinding when possible to reduce experimental bias

  • Detailed protocol documentation:

    • Record all experimental parameters meticulously

    • Include often overlooked details like buffer compositions, incubation times, and equipment settings

    • Share protocols through repositories or supplementary materials

  • Statistical approaches for assessing reproducibility:

    • Calculate coefficients of variation for replicate measurements

    • Implement appropriate statistical tests for reproducibility

    • Consider Bayesian approaches to incorporate prior knowledge about variability

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.